The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Bayer says glyphosate-cancer legal settlement should cap future liability, as number of lawsuits surges past 40,000

| | November 1, 2019

Already reeling from an avalanche of lawsuits, German agriculture and healthcare giant Bayer AG said on [October 30] the number of cases alleging the company’s glyphosate-based herbicides cause cancer more than doubled over the past three months, to 42,700.

Three U.S. juries have ruled against Bayer in cases brought by Americans alleging Monsanto’s popular herbicide caused their cancer …. Bayer, which says there is extensive scientific research showing that glyphosate-based herbicides are safe and do not cause cancer, is appealing the rulings and is participating in mediation, ordered by U.S. District Judge Vince Chhabria.

Law firms in the U.S. have been running TV ads advising people with cancer who have used glyphosate-based herbicides to consult them. [Company CEO Werner] Baumann said Bayer was engaging constructively in the mediation with a view to finding a solution …. He said Bayer would only accept a mediation outcome that is “financially reasonable and is structured in a way that will bring the matter to a reasonable conclusion.”

Related article:  EU Parliament, bucking EU Commission, opposes authorization of five new GMOs

That means Bayer wants any settlement to cover potential future claims, giving it assurances that there would be a cap on its liability.

Read full, original article: As Roundup Lawsuits Pile Up by the Thousands, Bayer Remains Defiant

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend